AOD 9604: an N-tyrosyl analog of the lipolytic fragment of human growth hormone [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 71300630 |
| MeSH ID | M0408152 |
| Synonym |
|---|
| 7up768ip4m , |
| aod 9604 |
| aod-9604 |
| 221231-10-3 |
| unii-7up768ip4m |
| aod9604 |
| l-phenylalanine, l-tyrosyl-l-leucyl-l-arginyl-l-isoleucyl-l-valyl-l-glutaminyl-l-cysteinyl-l-arginyl-l-seryl-l-valyl-l-.alpha.-glutamylglycyl-l-seryl-l-cysteinylglycyl-, cyclic (7->14)-disulfide |
| tyr-leu-arg-ile-val-gln-cys-arg-ser-val-glu-gly-ser-cys-gly-phe cyclic (7->14)-disulfide |
| EX-A4625 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (56.92) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 3 (37.50%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (62.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||